Literature DB >> 7676985

Ovarian carcinoma: value of CT in predicting success of debulking surgery.

J I Meyer1, A W Kennedy, R Friedman, A Ayoub, R C Zepp.   

Abstract

OBJECTIVE: Initial therapy for metastatic epithelial ovarian adenocarcinoma involves aggressive surgery to remove as much tumor as possible. However, this procedure is not beneficial for patients unless tumor implants can be reduced to less than 2 cm in diameter. This study was performed to determine whether CT can be used to predict the success of debulking surgery and thereby spare some patients from an unnecessary operation.
MATERIALS AND METHODS: Preoperative CT scans of 28 women who underwent primary surgery for ovarian carcinoma were retrospectively reviewed (18 patients had extrapelvic [stage III or IV] disease at surgery). Five regions were analyzed for evidence and extent of metastatic disease (omentum, liver, small bowel mesentery, paraaortic nodes, and diaphragm), and a score of 0-2 (see below) was assigned to each. These scores were added together for a total score of 0-10, which was compared with the surgical results. Receiver operating characteristic curve analysis was used to assess the ability of the scoring system to predict which patients would benefit from tumor debulking. Patient age, serum CA-125 level, and amount of ascites were also examined.
RESULTS: On a 10-point preoperative CT scoring system, a score of 3 or higher identified patients whose tumors were not successfully debulked with a sensitivity of 58% (7/12) and a specificity of 100% (16/16). The area under the receiver operating characteristic curve for this system was 0.94. The use of additional parameters, such as extent of ascites, serum CA-125 level, or age, did not improve accuracy.
CONCLUSION: Our results show that CT can be used to predict the success of primary debulking surgery in women with metastatic ovarian carcinoma. A significant number of patients in whom the surgery will have no benefit can be identified.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676985     DOI: 10.2214/ajr.165.4.7676985

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Authors:  Stephanie Nougaret; Yulia Lakhman; Mithat Gönen; Debra A Goldman; Maura Miccò; Melvin D'Anastasi; Sarah A Johnson; Krishna Juluru; Angela G Arnold; Ramon E Sosa; Robert A Soslow; Hebert Alberto Vargas; Hedvig Hricak; Noah D Kauff; Evis Sala
Journal:  Radiology       Date:  2017-06-16       Impact factor: 11.105

2.  Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma.

Authors:  Mohamed A F Hegazy; Refaat A F Hegazi; Mohamed A Elshafei; Ahmed E Setit; Maged R Elshamy; Mohamed Eltatoongy; Amal A F Halim
Journal:  World J Surg Oncol       Date:  2005-08-31       Impact factor: 2.754

Review 3.  A framework for a personalized surgical approach to ovarian cancer.

Authors:  Alpa M Nick; Robert L Coleman; Pedro T Ramirez; Anil K Sood
Journal:  Nat Rev Clin Oncol       Date:  2015-02-24       Impact factor: 66.675

4.  A rationale for neoadjuvant systemic treatment followed by surgical assessment and intraperitoneal chemotherapy in patients presenting with non-surgically resectable ovarian or primary peritoneal cancers.

Authors:  Maurie Markman; Jerome Belinson
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-21       Impact factor: 4.553

5.  The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer.

Authors:  Gretchen Glaser; Michelle Torres; Bohyun Kim; Giovanni Aletti; Amy Weaver; Andrea Mariani; Lynn Hartmann; William Cliby
Journal:  Gynecol Oncol       Date:  2013-05-11       Impact factor: 5.482

6.  Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer.

Authors:  Dae Chul Jung; Sokbom Kang; Min Ju Kim; Sang Yoon Park; Hyun Beom Kim
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

7.  A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

Authors:  Rudy S Suidan; Pedro T Ramirez; Debra M Sarasohn; Jerrold B Teitcher; Svetlana Mironov; Revathy B Iyer; Qin Zhou; Alexia Iasonos; Harold Paul; Masayoshi Hosaka; Carol A Aghajanian; Mario M Leitao; Ginger J Gardner; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Hedvig Hricak; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2014-07-11       Impact factor: 5.482

Review 8.  Ovarian cancer: the clinical role of US, CT, and MRI.

Authors:  Kaori Togashi
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

Review 9.  MR imaging in ovarian cancer.

Authors:  S A A Sohaib; R H Reznek
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

10.  Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.

Authors:  G Ferrandina; G Sallustio; A Fagotti; G Vizzielli; A Paglia; E Cucci; A Margariti; L Aquilani; G Garganese; G Scambia
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.